CTRI/2023/07/055562招募中2 期
An open label, single arm clinical study of Gokshurakadi Churna in the management of Klaibya (Erectile dysfunction)
SDM College of Ayurveda and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Minimum 3 months history of erectile dysfunction who are in a stable, monogamous relationship with a female partner.
- •2.Age-21 to 60 years.
- •3.Fairly good glycaemic condition HbA1C < 8%
- •4.Those subjects ready to participate and follow the instruction and sign the informed consent form.
排除标准
- •1. Any systemic disease with impaired cardiac, hepatic and renal functions that may interfere with the course of treatment.
- •2. Significant anatomical penile deformity requiring surgical correction.
- •3. Failure to achieve erection after radical prostatectomy or pelvic surgery.
- •4. Penile Implants.
研究者
相似试验
尚未招募
4 期
Effect of Gokshurak Rasayana in Chronic Kidney Disease(Mutravaha SrotasDusti)CTRI/2023/02/049594Ch Brahm Prakash Ayurved Charak Sansthan Khera Dabar
尚未招募
3 期
IN Ayurveda rog Mutrakrichra w.s.r. to Urinary Tract infection par Gokshuru Kwatha ka EffectCTRI/2023/08/056976RG GOVt PG Ayurvedic college paprola HP
尚未招募
2 期
Role of certain ayurvedic drugs given by oral and topical(ear) route in the management of ear dischargeCTRI/2021/07/035178ational institute of Ayurveda
进行中（未招募）
1 期
Investigating the safety and efficacy of a Universal CAR-T cell immunotherapy in patients with relapse and refractory T-cell acute lymphoblastic leukemia and T lymphoblastic lymphomaRelapse and Refractory T cell acute lymphoblastic leukaemia (T-ALL), Relapse and Refractory T cell lymphoblastic lymphoma (T-LBL)Acute lymphoblastic leukaemia, lymphoblastic T-cell lymphomaCancerISRCTN19144142Gracell Biotechnologies Co., Ltd15
进行中（未招募）
1 期
Investigating the safety and efficacy of a Universal CAR-T cell immunotherapy in patients with relapse and refractory B-cell acute lymphoblastic leukemia and B lymphoblastic lymphomaCancerISRCTN11885863Gracell Biotechnologies Co., Ltd15